Effect of Spironolactone on Kidney Function in Kidney Transplant Recipients: A Randomized Placebo-Controlled Clinical Trial

CONCLUSION: Spironolactone added to standard therapy for three years in kidney transplant patients did not improve kidney function, long-term proteinuria or interstitial fibrosis.PMID:38416033 | DOI:10.2215/CJN.0000000000000439

Source: Clinical Journal of the American Society of Nephrology : CJASN - February 28, 2024 Category: Urology & Nephrology Authors: Line A Mortensen Bente Jespersen Anne Sophie L Helligsoe Birgitte Tougaard Donata Cibulskyte-Ninkovic Martin Egfjord Lene Boesby Niels Marcussen Kirsten Madsen Boye L Jensen Inge Petersen Claus Bistrup Helle C Thiesson Source Type: research